GE Healthcare
Patient Side Module, E-PSM, E-PSMP For continuous hemodynamic monitoring
Multiparameter hemodynamic module with simultaneous measurement of 3-, 7- or 12-lead ECG in S/5 modular monitors and 3-, 7-, 8- or 12-lead ECG in CARESCAPE* modular monitors, both with ST segment analysis, respiration, pulse oximetry, two temperatures, non-invasive blood pressure and optional two invasive blood pressures (in E-PSMP).
SpO2 features • Specified accuracy even with moving and restless patients • The scale of plethysmographic waveform can be fixed or set to autoscale according to the user selection • Variety of SpO2 sensors for various applications
ECG features • Continuous 3-, 7-, 8-, and 12-lead ECG with 3, 5, 6, or 10 leadwires and ST segment analysis with CARESCAPE modular monitors • Continuous 3-, 7- and 12-lead ECG measurement with 3, 5 or 10 leadwires and ST segment analysis with S/5 modular monitors • Manual storage of up to six reference QRS complexes • Manual or automatic creation of ST snapshots with CARESCAPE modular monitors‘ ST alarms capability • Compatible with the wide range of Multi-Link* cables and leadwire sets • Lethal arrhythmia analysis is standard with full arrhythmia recognition as a monitor software option
Non-invasive blood pressure (NIBP) features • Direct keys on the module for starting or stopping a single measurement, or initiating or stopping a NIBP cycle • Venous stasis for easy cannulation • Visual indicator for elapsed time from previous measurement • Automatic BP hose detection for adult and infant cuffs
Respiration rate features • Adjustable trigger level with breath indicator • Specific slow waveform speed to see different respiratory patterns
• Excellent signal quality due to advanced electrical interference filtering
Invasive blood pressure features
• QT/QTc values are calculated with 5, 6 or 10 leadwires with CARESCAPE modular monitors
• Waveforms displayed with combined or individual scales
• 12SL* and 12RL* 12-lead ECG analysis available with CARESCAPE modular monitors
• Selectable labels for invasive blood pressures • A dedicated wedge pressure (PCWP) measurement display view • Adjustable cursor to detect changes in the invasive pressure waveform
Technical Data Impedance respiration
Direct function keys Auto On/Off
Starts/stops NIBP cycle
Measurement method
Transthoracic impedance
Start/Cancel
Starts/stops single NIBP
Measuring range
Impedance, 0.2 to 32 Ohm
Zero P1
Zeros invasive blood pressure P1
Max base impedance
5 kOhm
Zero P2
Zeros invasive blood pressure P2
Respiration range
4 to 120 breath/min
ST segment analysis ST segment measured and displayed simultaneously for up to 12 ECG leads ST level range CARESCAPE modular monitors
-20 to 20 mm
S/5 modular monitors
-9 to 9 mm 0.1 mm
Averaging
Calculated from 8 QRS complexes
ST trends up to 72 hours
S/5 modular monitors up to 72 hours (ICU) up to 24 hours (ANE) QRST complex storage
ne complex stored every O 10 minutes and manual storing of 6 complexes
Alarms CARESCAPE modular monitors
S/5 modular monitors
Âą5% or Âą5 breath/min
Update
10 s
Display resolution
1 breath/min
Sweep speed (trace)
Slow 0.625 mm/s, fast 6.25 mm/s
Alarms
Adjustable high and low alarm limits for respiration rate, apnea
Note: Impedance respiration measurement is intended for patients over three years old.
Display resolution
CARESCAPE modular monitors
Accuracy
djustable high and low alarm A limits for anterior, inferior, lateral and individual leads djustable high and low alarm A limits for anterior, inferior and lateral leads
WARNING: CARESCAPE modular monitors: Apnea events -- The monitor may not detect all episodes of inadequate breathing, nor does it distinguish between central obstructive and mixed apnea events. S/5 monitors: These devices are not apnea monitor systems intended to alarm primarily upon the cessation of breathing. In central apnea it indicates an alarm after a predetermined time since the last breath detection. Do not attempt to use these devices for detecting obstructive or mixed apneas, since respiration movements and impedance variations may continue in these cases.
ECG Measurement method CARESCAPE modular monitors
3, 7, 8 and 12 lead ECG with 3, 5, 6 or 10 leadwires
S/5 modular monitors
3, 7 and 12 lead ECG with 3, 5 or 10 leadwires
ECG Lead selection It is possible to monitor simultaneously one or more of the following leads: CARESCAPE modular monitors
I, II, III, aVL, aVF, aVR, V1, V2, V3, V4, V5, V6, dV2, dV3, dV4, dV6
S/5 modular monitors
I, II, III, aVL, aVF, aVR, V1, V2, V3, V4, V5, V6
NOTE: All specifications are relevant to S/5 and CARESCAPE modular monitors, unless otherwise noted.
Heart rate
Filter modes
Measurement range CARESCAPE modular monitors
30 to 300 bpm
S/5 modular monitors
30 to 250 bpm
Measurement accuracy
±5% or ±5 bpm
Display resolution
1 bpm
Display averaging time CARESCAPE module monitors
10 s median values
S/5 modular monitors Average of 12 s median values, or 5 s, depending on monitor Display update time CARESCAPE modular monitors
1s
S/5 modular monitors
5 s or 1 s, depending on monitor
50 Hz power supply frequency: Monitoring filter: 0.05 to 32 Hz Diagnostic filter: 0.05 to 150 Hz
60 Hz power supply frequency: Monitoring filter: 0.05 to 40 Hz Diagnostic filter: 0.05 to 150 Hz
Moderate filter: 0.05 to 22 Hz Maximum filter: 5 to 25 Hz
S/5 modular monitors
50 Hz power supply frequency: Monitoring filter: 0.5 to 30 Hz ST filter: 0.05 to 30 Hz Diagnostic filter: 0.05 to 150 Hz
60 Hz power supply frequency: Monitoring filter: 0.5 to 40 Hz ST filter: 0.05 to 40 Hz Diagnostic filter: 0.05 to 150 Hz
Defibrillation protection
5000 V, 360 J
Sweep speed
Alarms CARESCAPE modular monitors
S/5 modular monitors
Asystole
Asystole
Leads-off detection
Leads-off detection, bradycardia, tachycardia
Adjustable high and low Adjustable high and low alarm alarm limits for heart rate limits for heart rate V Fib
V Fib
V Tach
V Tachy Rapid VT 1
CARESCAPE modular monitors
6.25, 12.5, 25 or 50 mm/s
S/5 modular monitors
12.5, 25 or 50 mm/s (15“ screen)
Gain CARESCAPE modular monitors
0.5x = 5 mm/mV 1x = 10 mm/mV 2x = 20 mm/mV 4x = 40 mm/mV
S/5 modular monitors
0.2 to 5.0 cm/mV
Pacemaker pulse detection
Optional:
Optional:
VT > 2
V Run > 3
Couplet
V Couplet
Bigeminy
V Bigeminy
Trigeminy
V Trigeminy
R on T
R on T PVC
Missing Beat
Missing Beat
Allowable offset
Multifocal PVCs
Multifocal PVCs
CMRR
Frequent PVCs
Frequent PVCs
CARESCAPE modular monitors
Detection level ±2 mV to ±700 mV Pulse duration 0.1 to 2 ms
S/5 modular monitors
Detection level ±2 mV to ±700 mV Pulse duration 0.5 to 2 ms ±1 Vdc
Frequent SVC 1
CARESCAPE modular monitors
≥ 90 dB minimum at 50 Hz
Idioventricular rhythm 1
S/5 modular monitors
≥ 95 dB
Long R-R 1 SV Tachy 1 Atrial fibrillation 1 1
CARESCAPE modular monitors
Only software version 07 and later.
Pacemaker detector may not operate correctly during the use of high-frequency (HF) surgical equipment. The disturbances of HF surgical equipment typically cause false positive pacer detection.
NOTE: All specifications are relevant to S/5 and CARESCAPE modular monitors, unless otherwise noted.
Invasive blood pressure Measurement method
Temperature Invasive blood pressure is converted to an electrical signal by a pressure transducer. The signal is continuously displayed as a waveform and numeric value. The invasive pressure setup consisting of connecting tubing, pressure transducer, an intravenous bag of normal saline all connected together by stopcocks, is attached to the catheter. The pressure transducer is placed at the same level with the heart and electrically zeroed
Measurement range
-40 to 320 mmHg
Measurement accuracy
±5% or ± 2 mmHg
Waveform display Range
-30 to 300 mmHg
Scales
Adjustable in 10 mmHg increments
Numerical display Resolution
1 mmHg
Alarms
Adjustable high and low alarm limits for systolic, diastolic and mean pressures
2 temperature measurement channels Measurement method
The temperature is measured by a probe whose resistance varies when the temperature changes
Temperature units
°C or °F
Numerical display
2 temperatures, differential T2-T1
Measurement range
10 to 45°C (50 to 113°F)
Measurement accuracy with sensors
±0.2°C (25 to 45°C) / ±0.4°F (77 to 113°F)
±0.3°C (10 to 24.9°C) / ±0.5°F (50 to 76.9°F)
Display resolution
±0.1°C (±0.1°F)
Probes
Use only GE Healthcare temperature probes or defibrillator-proof YSI 400 series probes
NIBP Numerical display
Systolic, diastolic and mean arterial pressure
Measurement principle
Oscillometric with linear deflation
Measurement range
Adult: Child: Infant:
Pulse rate CARESCAPE modular monitors
HR from ART, ABP
S/5 modular monitors
HR from ART
25 to 260 mmHg 25 to 190 mmHg 15 to 140 mmHg
Measurement intervals
Measurement range
30 to 250 bpm
Display resolution
1 bpm
Accuracy
±5% or ± 5 bpm
Transducer sensitivity
5 µV/V/mmHg
Pressure filter
0 to 22 Hz (-3 dB) adjustable upper limit 4 to 22 Hz
CARESCAPE modular monitors
1, 2, 2.5, 3, 4, 5, 10, 15, 20, 30 min, 1 h, 2 h, and 4 h or continous STAT mode
S/5 modular monitors
1, 2.5, 3, 5, 10, 15, 30 min, 1 h, 2 h, 4 h or continuous STAT mode
Alarms
NOTE: All specifications are relevant to S/5 and CARESCAPE modular monitors, unless otherwise noted.
Adjustable high and low alarm limits for systolic, diastolic, mean, cuff loose, cuff occlusion
Plethysmographic pulse waveform
Typical measurement time
Adult Infants
Safety features
Adult
Initial inflation pressure (mmHg)
170 150 120
Max. inflation pressure (mmHg)
280
200
145
Overpressure limit
320
220
160
Max. measurement time
120
120
75
23 seconds 20 seconds Child
Infant
Note: NIBP measurement is intended for patients weighing over 5 kg/11 lb.
Scales
2, 5, 10, 20, 50 mod% or automatic scaling
2 Accuracy is based on deep hypoxia studies with volunteered subjects during nonmotion conditions over a wide range of arterial blood oxygen saturations as compared to arterial blood CO-Oximetry. 3 About two-thirds of pulse oximeter measurements can be expected to fall within ±Arms of the value measured by a CO-oximeter. 4 Measurement modules using GE Ohmeda technology with OxyTip+* sensors have been validated for pulse rate accuracy over the specified range in bench top testing against a patient simulator. Note: For each SpO2 accessory, refer to the instructions for use in the accessory package for patient weight limits.
Environment specifications Operating conditions
Pulse oximetry (SpO2) Measurement method Measurement and display range Calibration range
Red and infrared light absorption SpO2 0 to 100% 70 to 100%, calibrated against functional oxygen saturation
Measurement accuracy2 (Arms)3
70 to 100%: ±2 digits (% SpO2) ±3 digits during clinical patient motion < 70% unspecified
Display resolution
1 digit (% SpO2)
10 to 40°C (50 to 104°F)
Relative humidity
10 to 90% non-condensing
Storage conditions Temperature
-25 to 70°C (-13 to 158°F)
Relative humidity
10 to 90% non-condensing
Physical specifications Dimensions (H x W x D)
14.0 x 5.1 x 13.2 (17.1) cm (5.5 x 2.0 x 5.2 (6.7) in)
Weight
0.6 kg (1.3 lb)
Warranty One year
Display averaging time CARESCAPE modular monitors
3 s, 12 s
S/5 modular monitors
Adjustable beat-to-beat, 10 s, 20 s
Alarms
Temperature
Adjustable high and low alarm limits for SpO2 and pulse rate, probe off, no probe, no pulse
Pulse rate Measurement and display range
30 to 250 bpm
Display resolution
1 bpm
Measurement accuracy 4
±5% or ±5 bpm, whichever is greater
NOTE: All specifications are relevant to S/5 and CARESCAPE modular monitors, unless otherwise noted.
© 2012 General Electric Company – All rights reserved. * GE, GE Monogram, 12RL, 12SL, CARESCAPE and OxyTip+ are trademarks of General Electric Company. General Electric Company reserves the right to make changes in specification and features shown herein, or discontinue the product described at any time without notice or obligation. Contact your GE representative for the most current information GE Healthcare Finland Oy, a General Electric company, doing business as GE Healthcare. GE Healthcare, a division of General Electric Company
About GE Healthcare GE Healthcare provides transformational medical technologies and services that are shaping a new age of patient care. Our broad expertise in medical imaging and information technologies, medical diagnostics, patient monitoring systems, drug discovery, biopharmaceutical manufacturing technologies, performance improvement and performance solutions services help our customers to deliver better care to more people around the world at a lower cost. In addition, we partner with healthcare leaders, striving to leverage the global policy change necessary to implement a successful shift to sustainable healthcare systems. Our “healthymagination” vision for the future invites the world to join us on our journey as we continuously develop innovations focused on reducing costs, increasing access and improving quality around the world. Headquartered in the United Kingdom, GE Healthcare is a unit of General Electric Company (NYSE: GE). Worldwide, GE Healthcare employees are committed to serving healthcare professionals and their patients in more than 100 countries. For more information about GE Healthcare, visit our website at www.gehealthcare.com.
GE Healthcare P.O. Box 900, FIN-00031 GE, Finland GE Direct United Kingdom: +44 (0)800 0329201 www.gehealthcare.com
EMEA DOC1133430 4/12 (Global version DOC1085720)